Close Menu

NEW YORK (GenomeWeb News) – Helicos BioSciences reported after the close of the market Tuesday that its second-quarter revenues fell around 29 percent, as its grant and service revenues declined year over year.

The Cambridge, Mass.-based single molecule sequencing technologies firm had total revenues of $577,000 for the three months ended June 30, compared to $809,000 for the second quarter of 2011. Its service revenue fell to $175,000 from $273,000, and its grant revenue dropped to $243,000 from $427,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.